Amprion and Modality.AI have formed a collaboration to explore the combined use of molecular biomarkers and artificial ...
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Verge Genomics, a clinical-stage biotechnology company transforming drug discovery using artificial intelligence and human data, ...
Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, and Modality.AI, a leader in AI-enabled multimodal clinical assessments, today announced ...
A research team led by Professor Wang Hongqiang from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences proposed a Global-Local Alignment Attention (GLAA) model based on an ...